REQUEST A DEMO
Total
USD $0.00
Search more companies

Biotecnologia y Medicina Bioamiga Cia. Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Biotecnologia y Medicina Bioamiga Cia. Ltda Profile Updated: April 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Biotecnologia y Medicina Bioamiga Cia. Ltda is based in Ecuador. The head office is in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on July 13, 2012. 4 (2024) employees currently work for Biotecnologia y Medicina Bioamiga Cia. Ltda. In its most recent financial highlights, the company reported a net sales revenue increase of 22.38% in 2025. There was a total growth of 170.26% in Biotecnologia y Medicina Bioamiga Cia. Ltda’s total assets over the same period.

Headquarters
Calle Altar, N50-49
Quito; Pichincha;

Contact Details: Purchase the Biotecnologia y Medicina Bioamiga Cia. Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Biotecnologia y Medicina Bioamiga Cia. Ltda report to view the information.
Registered Capital:
Purchase the Biotecnologia y Medicina Bioamiga Cia. Ltda report to view the information.
Financial Auditors:
Purchase the Biotecnologia y Medicina Bioamiga Cia. Ltda report to view the information.
Incorporation Date:
July 13, 2012
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
94.31%
Purchase this report to view the information.
5.69%
Company Performance
Financial values in the chart are available after Biotecnologia y Medicina Bioamiga Cia. Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
22.38%
Total Operating Revenue
22.38%
Operating Profit
-93.88%
EBITDA
100.31%
Total Assets
170.26%
Total Equity
168%
Operating Profit Margin
-15.85%
Debt / Equity
-59.3%
Quick Ratio
0.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?